£5-a-Day Weight Loss Pills Launch in the UK — Who Is Eligible?

  • تاريخ النشر: الجمعة، 12 يونيو 2026 زمن القراءة: دقيقة قراءة

A new once-daily GLP-1 option for eligible adults, with NHS access and pricing still undecided.

The New Medicine Is an Oral Wegovy Tablet

Adults With a BMI of 30 or Above Qualify

Some Overweight Adults Are Also Eligible

It Must Accompany Lifestyle Changes

Treatment Begins With a Low Dose

Approval Does Not Mean Immediate NHS Access

The £5-a-Day Price Is Not Confirmed

Private Providers Are Building Waiting Lists

The Tablet Still Carries Side Effects

How It Is Taken Matters

  • 1 / 10
مقالات ذات صلة
Two Groups Set to Qualify for New Wegovy Weight Loss Pill on the NHS
New Weight-Loss Pills Are Coming to Major UK Pharmacies — Here’s Where
5 Morning Drinks That Help With Weight Loss

Britain has approved its first oral GLP-1 medicine specifically for weight loss, offering an alternative for eligible patients who do not want to use injections. The Medicines and Healthcare products Regulatory Agency authorised Novo Nordisk’s Wegovy tablet on June 11, 2026, after assessing its safety, quality and effectiveness.

However, the tablets have been approved rather than fully launched for sale, and the widely reported £5-a-day figure is not a confirmed UK retail price. Availability, private prescribing costs and any future NHS access will depend on separate decisions and commercial arrangements.

مواضيع ذات صلة